⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16796758 | 0.86 | — | — | |
| SCHEMBL16796731 | 0.86 | — | — | |
| SCHEMBL25899592 | 0.82 | — | — | |
| SCHEMBL740880 | 0.78 | DUT (0.34) | — | |
| SCHEMBL25899588 | 0.77 | — | — | |
| SCHEMBL31200 | 0.73 | — | — | |
| SCHEMBL25373236 | 0.71 | DUT (0.41) | — | |
| SCHEMBL15345786 | 0.71 | DUT (0.41) | — | |
| SCHEMBL15345823 | 0.71 | DUT (0.41) | — | |
| SCHEMBL25375053 | 0.71 | DUT (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234978-A1 | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF | Atrium Therapeutics, Inc. | 2023-07-27 | — | — | US | disclosed |